|
|
 |
|
Viewing report
|
|
|
|
European HIV/AIDS and Hepatitis B/C Molecular Diagnostics Market
Frost & Sullivan, June 2009, Pages: 54
This research service analyses the revenue potential for HIV/AIDS and Hepatitis B/C molecular diagnostics markets in major western European countries. It also gives the overview of the market in these regions together with market drivers,restraints and challenges in the whole Europe. Together it recommends strategies for the players in these markets to obtain best results in the European market.
Research Overview
This Frost & Sullivan research service titled European HIV/AIDS and Hepatitis B/C Molecular Diagnostics Market provides a comprehensive analysis of the European human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) and hepatitis biological/chemical (B/C) molecular diagnostics market. The analysis includes the factors driving market growth, industry challenges, revenue forecasts through 2015 and opportunities within the market. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets by region: Germany, France, Italy, Spain, the United Kingdom, Benelux and Scandinavia.
This analysis is available through our Drug Discovery & Clinical Diagnostics Growth Partnership Services programme. With continuous access to intelligence and resources from all seven perspectives of the Complex Business Universe, the Growth Partnership Services programme ensures that you and your Growth Team™ are able to maintain a 360 Degree Perspective of the market. This comprehensive, objective information allows your company to mitigate risk, identify new opportunities, and drive effective strategies for growth.
Market Overview
Rising Adoption of Automated Platforms Drives Growth and Innovation in the European HIV/AIDS and Hepatitis B/C Molecular Diagnostics Market
Molecular tests for the increasing cases of HIV/AIDS and hepatitis are well established in Europe due to their clinical significance and superior reimbursement structure. With the market moving towards the late growth stage, participants are attempting to innovate to stay ahead. The development of highly sensitive assays in automated platforms has become a major differentiating factor for companies in this market. “A rise in the adoption of automated platforms by laboratories is spurring innovation and driving growth in the European HIV/AIDS and hepatitis B/C molecular diagnostics market,” says the analyst of this research. “Furthermore, an increasing interest towards companion diagnostics boosts the implementation of genotyping tests.” The growing popularity for highly sensitive HIV/AIDS and hepatitis assays used to detect extremely low levels of viral ribonucleic acid (RNA) copies is encouraging innovation in the market. Novel automated platforms are a major revenue growth booster for the market participants. Additionally, a rising preference for genotyping tests to understand mutation patterns is further catalysing market growth.
However, stringent intellectual property rights keep a check on the revenue returns in this market. Approximately one third of the revenues are paid as royalties, severely affecting the profit margins. A fall in test prices due to competition further hinders revenue returns, restraining the development of this market. “Stiff competition within the market compels the participants to lower prices, consequently resulting in a fall in the cost of tests,” explains the analyst.
Companies should strike a balance between sales and R&D investments to remain competitive. They should actively focus on east European countries, which have higher incidences of newly diagnosed cases, in order to facilitate a favourable revenue flow. “Companies should differentiate themselves to successfully combat the fierce competition and make inroads into the infectious disease testing markets,” concludes the analyst. “One such differentiating factor would be to develop and offer diagnostic tests on emerging infections.”
Market Sectors
Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:
By Region:
- Germany
- France
- Italy
- Spain
- The United Kingdom
- Benelux
- Scandinavia
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
HIV/AIDS Testing - Global Strategic Business Report
Molecular Diagnostics - Technologies, Markets and Companies
Molecular Diagnostics in Infectious Disease Testing
Innovations in Molecular Diagnostics for Infectious Diseases
Rapid Advances in HIV/AIDS Clinical Diagnostics
The Future of Molecular Diagnostics: Innovative Technologies Driving Market Opportunities in Personalized Medicine
Molecular Diagnostics Markets
Growth Opportunities in Transfusion Diagnostic Testing
Molecular Diagnostics Market Report: 2011 Edition
Future Japanese Molecular Diagnostics Market: Growth Opportunities and Business Expansion Strategies
|
|
|
|
